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Background: Essential oils (EOs) are complex mixtures of secondary metabolites from various plants. It has been
shown that several EOs, or their constituents, have inhibitory activity against trypanosomatid protozoa. Thus, we
analyzed the biological activity of different EOs on Trypanosoma cruzi, as well as their cytotoxicity on Vero cells.
Methods: The following EOs were evaluated on T. cruzi epimastigote forms: Cinnamomum verum, Citrus limon,
Cymbopogon nardus, Corymbia citriodora, Eucalyptus globulus, Eugenia uniflora, Myrocarpus frondosus, and Rosmarinus
officinalis. Inhibitory activity against T. cruzi (IC50/24 h) and cytotoxicity against Vero cells (CC50/24 h) were evaluated
by the MTT assay. The EO of C. verum was selected for further evaluation against trypomastigotes and intracellular
amastigotes, as well as on parasite metacyclogenesis. Constituents of C. verum EO were identified by GC-MS.
One-way ANOVA statistical analysis was performed with GraphPad version 5.01.
Results: Cinnamomum verum EO was the most effective against T. cruzi epimastigotes (IC50/24 h = 24.13 μg/ml),
followed by Myrocarpus frondosus (IC50/24 h = 60.87 μg/ml) and Eugenia uniflora (IC50/24 h = 70 μg/ml). The EOs of
C. citriodora, E. globulus, and R. officinalis showed no activity at concentrations up to 300 μg/ml. Incubation of T.
cruzi metacyclic trypomastigotes and intracellular amastigotes with C. verum EO resulted in IC50/24 h values of
5.05 μg/ml and 20 μg/ml, respectively. Therefore, trypomastigotes are more susceptible than epimastigotes, with
selectivity index (SI) about 4.7-fold higher (9.78 and 2.05, respectively). Analysis of C. verum EO by GC–MS showed
mainly (E)-cinnamaldehyde (81.52%) and eugenol (16.68%).
Conclusions: C. verum essential oil is effective against T. cruzi (epimastigotes, trypomastigotes and amastigotes) and
interferes with the parasite differentiation process in vitro. Thus, it represents a strong candidate for further studies
to improve its activity on pathogenic trypanosomatids.
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Chagas disease, caused by the flagellate protozoan Try-
panosoma cruzi, is a chronic disease that occurs mainly
in Latin America. It is estimated that 7–8 million people
are infected worldwide [1]. Most infected people live in
endemic areas, comprising 21 Latin America countries
[1]. Chagas disease is technically considered a zoonosis,
as the natural reservoirs are marsupials and placental* Correspondence: maurilio@tecpar.br
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unless otherwise stated.mammals. The disease in humans results from the
invasion of natural ecotopes and the establishment of
vectors in human dwellings in endemic areas because of
poor socio-economic conditions in most rural popula-
tions [2].
T. cruzi is naturally transmitted by blood-sucking insects
of the subfamily Triatominae (Hemiptera: Reduviidae). Hu-
man infection occurs usually by insect bite, oral transmis-
sion, blood transfusion, or congenital transmission [2-4].
Transmission through blood transfusion, congenitally, and
with intense international migration, has led to spread ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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and Western Europe [2].
Two drugs emerged in the late 1960s for the
treatment of Chagas disease: benznidazole (Rochagan in
Brazil and Radanil in Argentina, from Roche) and nifur-
timox (Lampit, from Bayer). These two drugs are still
the only ones available for Chagas disease. Both drugs
were originally recorded for treatment of the acute
phase of Chagas disease, but are currently used in both
acute and initial chronic phases [2,5]. However, these
chemotherapeutic drugs do not completely fill the
World Health Organization (WHO) criteria for an ideal
drug, which are: (i) parasitological cure in acute and
chronic cases of infection, (ii) effectiveness in a single
dose or a few doses, (iii) accessibility to patients (low
cost and easy to achieve), (iv) no teratogenic or side
effects, (v) no need for hospitalization of patients for
treatment, and (vi) without showing resistance or induc-
tion of resistance to the etiological agent [6]. Further-
more, efficacy in the acute phase varies with the
geographical area, probably because of differences in
susceptibility between different strains of T. cruzi [2].
Maintenance of new cases in endemic regions and the
recent spread of the disease into non-endemic regions point
towards the need to find drugs that are effective both in
treatment of disease and prophylaxis of T. cruzi in blood
banks. Various drugs for the treatment of parasitic diseases
have been extracted from plants or synthesized from vegetal
prototypes [7,8]. Therefore, the study of extracts and com-
pounds with biological activity isolated from plants used in
folk medicine is promising in the search for compounds
with potential for the prophylaxis of Chagas disease.
Essential oils (EOs) are complex mixtures of second-
ary metabolites isolated from various plants, which may
be synthesized by all plant organs. In these mixtures
there are 20–60 constituents at different concentrations,
but usually only 2–3 major constituents determine the
biological properties of the EO [9]. Essential oils and
their constituents present a broad pharmacological
spectrum, and are used as antimicrobials, analgesics,
sedatives, anti-inflammatory, and anti-spasmodic drugs,
as well as anthelmintics and antiprotozoals [6,9-13].
It has been recently shown that several EOs, or their
constituents, have inhibitory activity against trypanoso-
matid protozoa [6,14-22]. However, most studies in T.
cruzi evaluated the inhibitory activity only on culture
epimastigotes and blood trypomastigotes. The data are
sparse on the effect of EOs, or their main constituents,
on cell differentiation (metacyclogenesis) and on T.
cruzi intracellular amastigotes. Thus, we have analyzed
the effect of different EOs, with emphasis on Cinnamo-
mum verum EO, on epimastigotes, trypomastigotes, and
amastigotes, as well as on the process of differentiation
in vitro (metacyclogenesis) of T. cruzi.Methods
Essential oils (EOs), (E)-cinnamaldehyde and Benznidazole
Essential oils of Cinnamomum verum (formerly Cinnamo-
mum zeylanicum; Lauraceae; cinnamon) bark, Citrus limon
(Rutaceae; lemon), Cymbopogon nardus (Poaceae; citronella
grass), Corymbia citriodora (formerly Eucalyptus citriodora;
Myrtaceae; lemon eucalyptus), Eucalyptus globulus (Myrta-
ceae; blue gum), Eugenia uniflora (Myrtaceae; pitanga),
Myrocarpus frondosus (Fabaceae; cabreúva), and Rosmari-
nus officinalis (Lamiaceae; rosemary) were purchased from
QUINARI Cosmetic and Fragrances Inc. (Maringá-PR,
Brazil). EOs from cinnamon and lemon eucalyptus were
from lot 05209; EOs of pitanga, blue gum, cabreúva, and
lemon were from lot 022186; citronella grass EO was from
lot 519/520; and rosemary EO was from lot 022185. All
EOs were valid until August 2012 and used from 2011–
2012. Benznidazole and (E)-cinnamaldehyde were pur-
chased from Sigma-Aldrich (St Louis, MO, USA).
EOs, (E)-cinnamaldehyde and benznidazole were first
diluted in dimethylsulfoxide (DMSO) at 100 mg/ml for
EOs, 50 mg/ml for benznidazole (192.14 mM), and
13.216 mg/ml (100 mM) for (E)-cinnamaldehyde (first
stock). For use, the first stock was diluted 1:50 (benznida-
zole) or 1:100 (EOs and cinnamaldehyde) in either LIT
(liver infusion tryptose) or RPMI-1640 (Sigma-Aldrich)
media (second stock). Therefore, DMSO was diluted to
1%, ensuring that its final concentration in the experi-
ments never exceeded 0.5%, a concentration that is not
harmful to parasites and Vero cells. These stocks were
stored at 4°C in the dark, to avoid degradation [23]. The
second stock was prepared minutes before use.Chemical composition of Cinnamomum verum
essential oil
Gas chromatography–mass spectrometry (GC–MS) ana-
lysis was performed using a Shimadzu GC-2010 gas chro-
matograph coupled with GCMS-QP2010 Plus equipped
with auto sampler (model AOC-20i, Shimadzu, Columbia,
MD, USA) and GC–MS Solution software. Analysis was
performed with a Rtx-5MS capillary column (30 mm×
0.25 mm× 0.25 μm), using temperature programmed con-
dition from 60°C to 250°C at 3°C/min. Analysis conditions
were: injector temperature 250°C, ion source interface
temperature 300°C, analysis of masses between 40–350m/z,
electron impact at 70 eV, column head pressure at constant
pressure of 59 kPa, column flow 1.02 ml/min, gas linear
velocity: 36.8 cm/s, carrier gas: helium, injected volume: 1 μl
(1% dilution in hexane) in split mode (ratio 1:10). Constitu-
ents of the C. verum essential oil were identified by compar-
ing their mass spectral pattern and retention indices (RI)
relative to a standard n-alkane series (C9–C24) with those
given in the literature [24] and the Wiley 138 and Nist 98
databases.
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Epimastigotes (strain Dm28c) were maintained at 28°C in
LIT medium supplemented with 10% fetal calf serum
(FCS), with weekly passages. For the screening of EO
activity, epimastigotes were collected from cultures at the
mid log phase of growth (3-days-old). Parasite concentra-
tion was adjusted to 1 × 107 cells/ml and 180 μl/well were
added to a 96 well plate (1.8 × 106 parasites/well). Then
20 μl of compounds (final concentration: 5–300 μg/ml for
EOs, 0.26–39.65 μg/ml [2–300 μM] for (E)-cinnamalde-
hyde, and 6.25–150 μg/ml [0.024–0.576 mM] for benzni-
dazole) were added to each well. In control wells, 20 μl of
culture medium were added without the compounds. The
plates were incubated for 24 h at 28°C and then 50 μl of
MTT (at 10 mg/ml in PBS) was added to each well (final
concentration: 2 mg/ml per well). The plates were
wrapped in aluminum foil, incubated for 3 h at 37°C and
then centrifuged at 475 g for 10 min. The supernatant was
removed by abrupt plate inversion. Then 20 μl of 10%
SDS in 0.01 M HCl was added and the parasites were re-
suspended by gently tapping the plates. The plates were
then incubated at 37°C for 1 h. Thereafter, 80 μl of pure
DMSO was added to all wells to solubilize the formazan
crystals. Optical density (OD) was read at 550 nm in an
ELISA reader (Biotek model ELx800; Biotek, Winooski,
VT, USA). Mean of at least two independent experiments
was used to calculate the IC50/24 h using Microsoft Excel
software by linear correlation. Each experiment was
performed in triplicate.
Evaluation of EO activity on T. cruzi metacyclic
trypomastigotes
Purified metacyclic trypomastigotes were obtained in vitro
after nutritional stress in TAU3AAG medium, as previ-
ously described [25]. Briefly, 150 cm2 bottles were inocu-
lated with 5 × 106 epimastigotes/ml and after 72 h at 28°C
metacyclic trypomastigotes were released into the super-
natant. The cells were collected and purified by passage
through an affinity column containing DEAE cellulose
resin equilibrated with phosphate-saline-glucose buffer
(PSG: 47.47 mM Na2HPO4, 2.5 mM NaH2PO4 · H2O,
36.76 mM NaCl, 55.5 mM glucose). After purification, the
concentration of trypomastigotes was adjusted to 5 × 106
cells/ml and they were distributed into 24-well plates con-
taining TAU3AAG medium with different concentrations
(0–20 μg/ml) of C. verum EO. Cell lysis was determined
after 24 h by counting parasite density with a Neubauer
chamber. This density was used to calculate the IC50/24 h
(concentration leading to 50% cell lysis). The experiment
was performed in triplicate.
Evaluation of EO activity on T. cruzi amastigotes
Vero cells (ATCC: CCL-81) were kept at 37°C in a humidi-
fied 5% CO2 incubator, in 25 cm
2 culture flasks containingRPMI-1640 medium pH 7.4 supplemented with 2.5% FCS,
2 mM L-glutamine, 10 μg/ml streptomycin and 10 μg/ml
penicillin. For the experiments, the cells were seeded into
24-well plates and then infected with trypomastigotes at a
10 parasites/cell ratio. After 4 h the monolayers were
washed with PBS to remove non-internalized parasites and
kept for 12 h at 37°C in 1 ml RPMI/2.5% FCS in a 5% CO2
humidified atmosphere. After that, the EOs were added to
the RPMI medium at different concentrations (5–20 μg/ml)
and the plates were incubated for 24 h. The cells were then
stained with Giemsa and the whole well (total of nine fields)
was photographed in a Nikon TE300 inverted light micro-
scope, with a 20× objective.
Amastigote counting was performed using ImageJ soft-
ware, observing the percentage of infected cells, the number
of amastigotes/cell, and the total number of amastigotes/
well. Density of amastigote population was calculated divid-
ing the total number of amastigotes/well by the well area
(201 mm2). The percentage of inhibition (%I) was calculated
according to Guru et al. (1989) [26], as modified by Lakshmi
and collaborators (2007) [27], using the following formula:
%I = 100 − (T/C × 100), where T is the total number of
intracellular amastigotes in treated cells and C is the total
number of intracellular amastigotes in control cells. The
IC50/24 h value (concentration that inhibits proliferation of
intracellular amastigotes by 50%) was estimated from the%I
value with the Microsoft Excel software by linear correlation.
Statistical analysis (one-way ANOVA) of the data was
performed using the software GraphPad Prism Version 5.01
and data with p < 0.05 were considered significantly differ-
ent. The experiment was performed in triplicate.
Evaluation of EO activity on T. cruzi metacyclogenesis
Epimastigotes at late log phase of growth (cell density of
5–7 × 107 cells/ml) were collected by centrifugation for
5 min at 7000 g at 10°C, resuspended in triatomine arti-
ficial urine (TAU) medium at 5.0 × 108 cells/ml and kept
at 28°C for 2 h. Then, corresponding with nutritional
stress, the cells were transferred to 25 cm2 bottles con-
taining 5 ml of TAU3AAG medium (final concentration
of 5.0 × 106 cells/ml) with different concentration of C.
verum EO (4–145 μg/ml) and incubated at 28°C. After
24 h, the relative number of epimastigotes and trypo-
mastigotes was counted with a Neubauer chamber and
used to calculate the percentage of differentiation. Mean
inhibition of differentiation for each concentration (as
compared with metacyclogenesis in untreated control
cultures) was used to calculate the IC50/24 h using
Microsoft Excel software by linear correlation. The
experiment was performed in triplicate.
Cytotoxicity
Uninfected Vero cell monolayers were washed with PBS
pH 7.2, detached by treatment with 0.25% trypsin/0.1%
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pH 7.4 + 2.5% FCS, centrifuged at 0.2 g for 10 min at 4°C
and resuspended in the same medium. Cell viability was
assessed by Trypan Blue staining and the cells were
seeded into 96-well plates (2 × 104 cells/well). After 24 h,
the cells were incubated with EOs or cinnamaldehyde at
different concentrations (25–1000 μg/ml for EOs; 0.26–
39.64 μg/ml [2–300 μM] for cinnamaldehyde). After 24 h
of incubation, integrity of the cell monolayer was observed
under an inverted microscope and 50 μl of MTT (at
2 mg/ml in PBS) was added. After 4 h of incubation,
absorbance was read at 550 nm with an ELx800 (BioTek)
microplate reader. The mean of at least two independent
experiments was used to plot a graph of inhibition ×
concentration, which was used to calculate the CC50 (50%
cytotoxic concentration) using Microsoft Excel software
by linear correlation. Each experiment was performed in
triplicate.
Results
An initial screening of all EOs was performed on T. cruzi
epimastigotes, evaluating inhibitory activity at concentra-
tions of 50 μg/ml and 300 μg/ml. In this first trial, the
EOs of Rosmarinus officinalis, Eucalyptus globulus, and
Corymbia citriodora did not show activity at 300 μg/ml
and were therefore not further evaluated.
Lower concentrations of the remaining EOs were then
evaluated to estimate the IC50/24 h (Table 1). The most
effective EO was that of C. verum (IC50/24.13 ± 1.13 μg/ml;
IC90/24 h = 48.33 μg/ml), followed by M. frondosus (IC50/
24 h = 60.87 ± 1.13 μg/ml), and E. uniflora (IC50/24
h = 70 ± 1.04 μg/ml). The IC50/24 h of the reference drug
benznidazole was 15.8 ± 1.75 μg/ml (61 μM). Evaluation of
cytotoxicity on Vero cells showed that the least cytotoxic
EO was that of C. limon (CC50/24 h = 281.69 ± 1.12 μg/ml).
EOs with higher selectivity indexes were those from C.
limon (SI = 2.63), E. uniflora (2.46), M. frondosus (2.32), and
C. verum (2.05), but all were more cytotoxic and less select-
ive than benznidazole (CC50/24 h = 147.37 ± 1.22 μg/ml;
SI = 9.33).
Since the C. verum EO was notably more effective on T.
cruzi epimastigotes, it was selected for further evaluation
on other developmental forms (trypomastigotes and amas-
tigotes), as well as on the parasite differentiation processTable 1 EO activity on T. cruzi (IC50/24 h) epimastigotes and V
Essential oil IC50 epimastigotes (μg/ml)
Cinnamomum verum 24.13 ± 1.13
Myrocarpus frondosus 60.87 ± 1.13
Cymbopogon nardus 94 ± 1.14
Citrus limon 107.14 ± 1.03
Eugenia uniflora 70 ± 1.04
Benznidazole (reference drug) 15.8 ± 1.75 (61 μM)(metacyclogenesis). Metacyclogenesis was not significantly
affected by C. verum EO at concentrations up to 15 μg/ml.
Higher concentrations led to reduction in percentage of try-
pomastigotes and metacyclogenesis was totally abolished
with 25 μg/ml (IC50/24 h = 18.2 ± 1.04 μg/ml). After 48 h of
treatment with the IC50/24 h value, the surviving cells
showed slower motion compared with the control. After
treatment for 24 h with 35 μg/ml (2 × IC50/24 h) the few
remaining cells (epimastigote forms) were motionless.
On purified metacyclic trypomastigotes, the estimated
IC50/24 h was 5.05 ± 1.03 μg/ml (IC90 = 8.21 μg/ml), show-
ing that this form is more susceptible than epimastigotes.
The selectivity index (SI) increased more than 4-fold as
compared with epimastigotes (9.78 and 2.05, respectively).
Vero cells were first infected and then incubated with
C. verum EO, to assure that the effect was on amastigote
proliferation and not on adhesion/penetration of the
trypomastigotes used in the infection. Treatment with
20 μg/ml reduced the number of total amastigotes by
50% when compared with control infection, resulting in
an IC50/24 h value of 20 μg/ml (Table 2; Figures 1
and 2). The number of amastigotes/mm2, the association
index, and the percent inhibition (%I) were also reduced
by half, when compared with the untreated infection
(Table 2). The mean number of amastigotes per cell
decreased from 7.52 (untreated control) to 5.08 (Table 2;
Figure 2).
GC–MS analysis identified five main constituents in C.
verum EO, the major constituents being (E)-cinnamalde-
hyde (81.52%) and eugenol (16.68%), followed by (E)-
caryophyllene, (E)-cinnamyl acetate, and α-humulene
(Table 3). Since (E)-cinnamaldehyde was identified as the
main constituent, it was further evaluated against T. cruzi
epimastigotes and Vero cells, by the MTT colorimetric
assay. However, it showed no activity or cytotoxicity at
low concentrations up to 39.65 μg/ml (300 μM).
Discussion
Interest is growing in the search for natural compounds
active against pathogenic trypanosomatids, resulting in
several reports on the biological activity of essential oils
(EOs) or their main constituents on these protozoa
[6,18-20]. This activity is probably related to the function
of EOs in nature, where they play a protective role inero cells (CC50/24 h)
CC50 Vero cells (μg/ml) Selectivity index (SI)
49.4 ± 1.12 2.05
141.3 ± 1.14 2.32
178.95 ± 1.1 1.90
281.69 ± 1.12 2.63
172.42 ± 1.15 2.46
147.37 ± 1.22 9.33
Table 2 Effect of C. verum EO on T. cruzi intracellular amastigotes after treatment for 24 h
% Infected cells Total intracellular amastigotes Amastigotes/cell (mean) Density amastigotes/mm2 AIa %Ib
Control 59 (n = 5812) 25746 7.52 42.7 442.5 -
10 μg/ml 51.8 (n = 5709) 20315 6.87 33.7 355.87 21.1
20 μg/ml 50.6 (n = 4946) 12717 5.08 21.1 257.05 50.61
aAssociation Index (AI) =% infected cells × amastigotes/cell.
b% Inhibition (%I) = 100 − (T/C × 100), where T is the total number of intracellular amastigotes in treated cells and C is the total number of intracellular amastigotes
in control cells.
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protection against herbivory [9].
We have here first screened the activity of different EOs
on T. cruzi culture epimastigotes, which are easier to grow
and thus represent a simple model for the identification of
potential compounds active against this parasite. However,
in vitro activity against T. cruzi epimastigotes does not
guarantee promising activity against other forms of the
parasite. In fact, a considerable number of plant extracts
with positive inhibitory effects in vitro do not become al-
ternative chemotherapies [28]. Therefore, a large number
of EOs or their constituents and derivatives should be
analyzed, until a promising molecule acting on different
developmental stages of T. cruzi can be obtained.
Among the eight essential oils that we analyzed, the C.
verum EO showed the most activity against T. cruzi
epimastigotes. It has been shown that Cinnamomum sp.
EO has antipyretic, antibacterial, antifungal, antipara-
sitic, and repellent activities [9,28-31]. However, despite
its good inhibitory activity on T. cruzi, its IC50/24 h was
still higher than that of the reference drug benznidazole,
suggesting the need for high concentrations for in vivo
studies. Nevertheless, it has been shown in treatment of
mice that high concentrations of Cymbopogon citratus
EO produce no toxic effects [32]. This finding indicates
that EOs (or their main constituents) may have better
activity in vivo than in vitro, with activity on parasitic
infections and no cytotoxic activity [32,33]. Further-
more, treatment of mice with EOs showed beneficialFigure 1 Vero cells infected with T. cruzi and then treated with C. ver
for 24 h with 20 μg/ml C. verum EO. Note the decrease in amastigote (arroeffects not related to the parasite infection, such as re-
ductions in plasma cholesterol [32]. Therefore, C. verum
EO (or cinnamaldehyde derivatives) is a potential candi-
date in the search for trypanocidal chemotherapeutic
drugs.
Although it did not have the best selectivity index (SI)
on epimastigotes, the C. verum EO was effective at a
concentration much lower than that of the other EOs
that we evaluated. It was also effective on T. cruzi epi-
mastigotes at concentrations lower than those previously
obtained with EOs from Origanum vulgare (oregano),
Thymus vulgaris (thyme), Achillea millefolium (yarrow),
Syzygium aromaticum (clove), Ocimum basilicum (basil),
and Cymbopogon citratus (lemon grass), or their main
constituents [18-20]. Activity of the C. verum EO was
also higher than that obtained with other EOs used
against other pathogenic trypanosomatids [14,16,17,34].
On T. cruzi amastigotes, the C. verum EO was effect-
ive with IC50/24 h = 20 μg/ml (SI = 2.47), a value similar
to that found with epimastigotes. Its activity was better
than that obtained with jacaranone (main constituent of
Pentacalia desiderabilis), which showed no activity on
intracellular amastigotes of T. cruzi and Leishmania
chagasi at a concentration of 100 μg/ml [35]. However,
the IC50/24 h value found here was four times higher
than that obtained by Santoro and colleagues [18] with
Cymbopogon citratus EO (IC50/24 h = 5.1 μg/ml), al-
though the SI was similar to that obtained with Lippia
alba EO [36].um essential oil (EO). (A) Control, without treatment; (B) Treatment
ws) number after treatment. Bar = 100 μm.
Figure 2 Number of intracellular amastigotes in Vero cells
infected with T. cruzi. Amastigote counting was performed in
cultures without treatment (control) or after treatment for 24 h with
10 or 20 μg/ml C. verum EO. (A) Number of total amastigotes per
well; (B) Number of amastigotes per cell. ***Statistically different
from control and treatment with 10 μg/ml (p < 0.0001); **Statistically
different from control and treatment with 10 μg/ml (p < 0.0029).
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Cymbopogon citratus EO, was able to inhibit differenti-
ation of T. cruzi at a concentration of 30.8 μg/ml [37].
Our data showed that C. verum EO also interfered with
metacyclogenesis of this parasite. The differentiation
process was totally inhibited with 25 μg/ml. At this con-
centration, only epimastigotes forms could be observed
in the culture supernatant. Although it is possible that
the EO was killing the trypomastigote forms, we cannot







RI calc: Retention Index calculated; RI lit: Retention Index from the literature [24].also due to killing of epimastigotes prior to the differen-
tiation process, thus lowering the number of resulting
trypomastigotes.
The C. verum EO presented higher activity on T. cruzi
purified metacyclic trypomastigotes, increasing the SI to
9.78. This increase in SI, as compared with epimasti-
gotes, has been already observed [18,19]. Such difference
may be related to diverse metabolic pathways and mem-
brane composition in the various developmental forms
of T. cruzi. It is also possible that the composition of the
different culture media used for the various forms of T.
cruzi (LIT, RPMI-1640 and TAU3AAG media) may in-
fluence absorption and/or degradation of the EOs.
Several factors, such as part of the plant from which
the EO was extracted and season of cultivation, can alter
the composition of an EO and the concentrations of
each constituent [9-38]. Eugenol and cinnamaldehyde
have been reported as the main constituents in EOs of
Cinnamomum spp. [30,39,40]. Accordingly, our analysis
by GC–MS of the C. verum EO used in our experiments
also showed (E)-cinnamaldehyde (81.52%) and eugenol
(16.68%) as main constituents.
Based on differences in the composition of the EO
extracted from leaves of Cinnamomum osmophloeum,
Cheng et al. (2006) [30] classified it into six chemotypes,
according to the main component. The cinnamaldehyde
and cinnamaldehyde/cinnamyl acetate types had the
strongest antifungal activity, because of a higher concen-
tration of cinnamaldehyde. Singh and colleagues (2007)
[40] also attributed the antifungal effect of Cinnamomum
zeylanicum EO to the high concentration of cinnamalde-
hyde. The C. verum EO that we investigated had mostly
cinnamaldehyde in its composition, which suggests that
its activity could be related to this component. However,
(E)-cinnamaldehyde was not effective against T. cruzi
epimastigotes at low concentrations up to 300 μM
(39.648 μg/ml). (E)-cinnamaldehyde was active against T.
brucei trypomastigotes (IC50 = 2.93 μg/ml [41]), which
indicates different susceptibilities among different patho-
genic trypanosomatids and different developmental forms.
The tetrazolium dye MTT can be used to measure cyto-
toxicity (loss of viable cells: trypanocidal) or cytostatic
activity (trypanostatic) of potential drugs. MTT reduction
occurs via NAD(P)H-dependent oxidoreductase enzymessis
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[42,43]. MTT reduction is associated not only with
mitochondria, but also with the cytoplasm and with
non-mitochondrial membranes including the endo-
some/lysosome compartment and the plasma mem-
brane [42]. Thus, low optical density of MTT staining
can indicate low metabolic activity (trypanostatic) or
low number of cells (trypanocidal). In our experiments,
all plates were observed in inverted microscope before
the MTT assay, to assess possible EO activity. In these
observations we could see fewer cells and increased
cellular debris (as compared with the untreated control)
with increasing EO concentration (data not shown).
Therefore, our data indicate that C. verum EO has a
trypanocidal effect.
Activity of cinnamon EO could be associated with the
lipophilic characteristic of its constituents. As typical
lipophilic molecules, they cross the cell membrane and
once inside the cells, cinnamaldehyde could interact
with a variety of proteins, forming covalent bonds with
amino acid residues, inactivating enzymes, and affecting
a number of cellular activities. The mode of action
against T. cruzi could be via addition of an aldehyde
thiol to sulfur-containing components in the key en-
zymes trypanothione and trypanothione reductase [41],
which would lead to a redox imbalance (detected by the
MTT assay). Therefore, it is possible that C. verum EO
acts inside trypanosomes by promoting redox imbalance
in the cytosol.Conclusions
Biological activity of eight different essential oils was
screened against Trypanosoma cruzi epimastigotes. The
essential oils of C. verum, M. frondosus, and E. uniflora
showed the best activity and are promising agents
that deserve further study. C. verum essential oil was
effective on the three developmental forms of T. cruzi
(epimastigotes, trypomastigotes, and amastigotes) and
on the in vitro differentiation of this parasite. C. verum
essential oil was as effective as, or more effective than,
other essential oils or their main constituents tested on
trypanosomatids. Evaluation of cinnamaldehyde deriva-
tives is as a potential strategy for further studies to find
increased selectivity on T. cruzi and identification of the
mode of action against this parasite.Competing interests
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